Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CSPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UCHL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SLC46A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF197 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDFIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLRX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNAPC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDLIM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAR1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLGA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAP1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NT5C2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRELID3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on